Stocks›Healthcare
WatchAlert

GlaxoSmithKline Pharmaceuticals Limited

GLAXO · NSE · Healthcare · As of 8 Nov 2026
₹2,539.60
+₹14.80 (+0.59%)(1D)
₹2,088.1052 Week Range₹3,120.70
Market Cap
₹43,019 Cr
P/E (Sector)
41.5 (32.3)
P/B Ratio
18.97
Dividend Yield
2.24%
ROE
45.3%
Debt / Equity
0.00
Anvest Score
75/100
  • Valuation
    53
  • Quality
    100
  • Growth
    66
  • Health
    100
  • Momentum
    52

Fundamentals

P/E Ratio (TTM)
41.51
Sector median P/E
32.29
P/B Ratio
18.97
Sector median P/B
4.4
EPS (TTM)
₹61.18
Market Cap
₹43,019 Cr
Dividend Yield
2.24%
ROE
45.34%
ROCE
66.47%
Profit Margin
26.11%
Debt/Equity
0
Current Ratio
1.98
Interest Coverage
516.02
Book Value
₹133.86
Loading technical indicators…
Loading financial statement…
Loading shareholding…
Loading filings…

GlaxoSmithKline Pharmaceuticals Limited FAQs

3 topics
Expand
What does the GlaxoSmithKline Pharmaceuticals Limited (GLAXO) stock page cover?
GlaxoSmithKline Pharmaceuticals Limited on Anvest includes delayed price context, valuation ratios, a one-year price range, and section-level research data when available.
What are the current headline metrics for GLAXO?
GlaxoSmithKline Pharmaceuticals Limited is currently shown with a delayed price near ₹2,539.6, P/E 41.51, and ROE 45.34%.
Does the GLAXO page provide investment advice?
No. The GLAXO page is built for research, comparison, and planning. It does not publish buy, sell, or hold recommendations.
Keep exploring

Related insights